INGRID RIZO: Open Payments
NPI 1265050918 · DEERFIELD BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 15 payments from 7 companies in 2025. Trend: 2023 $1,267 · 2024 $1,331 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $314 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $150 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Novo Nordisk Inc | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $21 |
Products named: REPATHA, JARDIANCE, LEQVIO, ENTRESTO, Ozempic, VERQUVO, FARXIGA, LifeVest.
Industry payments across FL — which companies pay providers there.
